Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 6,916 $ 6,888
Trading marketable securities 8,567 9,150
Available-for-sale securities (amortized cost of $0 and $1,502, respectively) 0 1,495
Prepaid expenses and other current assets 903 789
Total Current Assets 16,386 18,322
Operating lease right-of-use assets 50 60
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 18,478 20,424
Current Liabilities    
Accounts payable and accrued liabilities 701 905
Due to related parties 87 53
Operating lease liabilities - current portion 37 40
Total Current Liabilities 825 998
Operating lease liabilities 15 23
TOTAL LIABILITIES 840 1,021
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized as of March 31, 2023 and December 31, 2022, 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized as of March 31, 2023 and December 31, 2022, 2,855,688 and 2,855,688 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 3 3
Additional paid-in capital 51,029 50,675
Accumulated deficit (33,189) (31,021)
Accumulated other comprehensive loss (205) (254)
TOTAL STOCKHOLDERS' EQUITY 17,638 19,403
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 18,478 $ 20,424